Figure 1 (090c23ad 1044 4f4c 9de4 1ca5bf487847 01)
Valganciclovir Tablet, Film Coated
Product Images NDC 42291-973
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 42291-973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Estimated Creatinine Clearance (090c23ad 1044 4f4c 9de4 1ca5bf487847 02)
This text appears to provide formulas for calculating certain values based on age, body weight, and serum creatinine levels. However, without further context or clarification, it is difficult to determine what specifically these formulas are used for.*
Image (090c23ad 1044 4f4c 9de4 1ca5bf487847 03)
1 (973 60)
AVKARE is a pharmaceutical company that produces Valganciclovir Tablets, which are used for medical purposes. The tablets are only available with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
